Compound 3K attenuates isoproterenol-induced cardiac hypertrophy by inhibiting pyruvate kinase M2 (PKM2) pathway.

Rihan, Mohd; Sharma, Shyam Sunder

Rihan, Mohd; Sharma, Shyam Sunder.

Affiliation

Rihan M; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar (Mohali) 160062, Punjab, India.
Sharma SS; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar (Mohali) 160062, Punjab, India. Electronic address: sssharma@niper.ac.in.

Life Sci ; 351: 122837, 2024 Aug 15.

Article de En | MEDLINE | ID: mdl-38879156

Sujet(s)
Mots clés

Cardiac hypertrophy; Cardiovascular diseases; Compound 3K; Pyruvate kinase M2

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pyruvate kinase / Cardiomégalie / Isoprénaline Limites: Animals Langue: En Journal: Life Sci Année: 2024 Type de document: Article Pays d'affiliation: Inde Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google